Anmeldung
Gruppen
Forscher/innen
Finanzierung
Ergebnisse
Linfomas
GLUN
Royal Adelaide Hospital
Adelaida, Australia
Sie sind in
Zusammenarbeiten
Royal Adelaide Hospital
Publikationen in Zusammenarbeit mit Forschern von Royal Adelaide Hospital (1)
2022
IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S387
Kontakt
Rechtlicher Hinweis
Hilfe
translate
de
arrow_drop_down
translate
de
arrow_drop_down
es
ca
eu
gl
en
fr